Switzerland vs Thailand: Access to anti-retroviral drugs, female
Switzerland
90.0%
in 2023
Thailand
90.0%
in 2024
Switzerland rank
27th
Thailand rank
27th
Access to anti-retroviral drugs, female over time
- Switzerland
- Thailand
How they compare
Switzerland currently reports 90.0% against 90.0% in Thailand, a difference of 0.0%.
Across all 24 years both countries report, Switzerland has been ahead every year.
Switzerland ranks 27th and Thailand ranks 27th of 141 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Switzerland | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.5% | 12.2% | 42.3% | Switzerland |
| 2010s | 83.6% | 53.9% | 29.7% | Switzerland |
| 2020s | 90.5% | 81.8% | 8.8% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Switzerland or Thailand?
- Switzerland, at 90.0% against 90.0% in Thailand as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Switzerland and Thailand?
- 0.0%, with Switzerland ahead.
- How many years of comparable data are there for Switzerland and Thailand?
- 24 years are reported by both, from 2000 to 2023.
- How do Switzerland and Thailand rank globally for access to anti-retroviral drugs, female?
- Switzerland ranks 27th and Thailand ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.